Current Report Filing (8-k)
2013年5月10日 - 5:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of
The Securities Exchange
Act of 1934
Date of Report (Date of earliest event reported)
May 8, 2013
Medifast, Inc.
(Exact name of registrant
as specified in its charter)
DE |
|
000-23016 |
|
13-3714405 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
11445 Cronhill Drive, Owings Mills, Maryland |
|
21117 |
|
|
(Address of principal executive offices) |
|
(Zip Code) |
|
Registrant's telephone number, including
area code: 410-581-8042
________________________________________________________________________________
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): |
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition.
On May 8, 2013, Medifast, Inc. issued a Press Release announcing
its earnings for the first quarter of 2013.
A copy of the Press Release is attached hereto as Exhibit 99.1.
This information is being furnished in this report and shall not be deemed to be "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as shall
be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit 99.1.
Press release dated May 8, 2013
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
Medifast, Inc.
|
|
Date: May 9, 2013
|
By: |
/s/ TIMOTHY G. ROBINSON
Timothy G. Robinson
Chief Financial Officer |
|
|
|
|
|
|
Exhibit Index |
|
|
|
99.1 |
Press release dated May 8, 2013 |
Medifast (NYSE:MED)
過去 株価チャート
から 6 2024 まで 7 2024
Medifast (NYSE:MED)
過去 株価チャート
から 7 2023 まで 7 2024